Zhengye Biotechnology Holding (ZYBT) Non-Current Assets (2023 - 2025)

Zhengye Biotechnology Holding has reported Non-Current Assets over the past 3 years, most recently at $42.2 million for Q4 2025.

  • Quarterly Non-Current Assets fell 4.06% to $42.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $42.2 million through Dec 2025, down 4.06% year-over-year, with the annual reading at $42.8 million for FY2025, 1.13% down from the prior year.
  • Non-Current Assets was $42.2 million for Q4 2025 at Zhengye Biotechnology Holding, roughly flat from $42.3 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $43.9 million in Q4 2024 and troughed at $42.2 million in Q4 2025.
  • The 3-year median for Non-Current Assets is $42.7 million (2023), against an average of $42.9 million.
  • Year-over-year, Non-Current Assets rose 1.86% in 2024 and then decreased 4.06% in 2025.
  • A 3-year view of Non-Current Assets shows it stood at $43.1 million in 2023, then rose by 1.86% to $43.9 million in 2024, then dropped by 4.06% to $42.2 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Non-Current Assets are $42.2 million (Q4 2025), $42.3 million (Q2 2025), and $43.9 million (Q4 2024).